Yao Xudong, Sun Kai, Yu Shengnan, Luo Jiahui, Guo Jiachao, Lin Jiamin, Wang Genchun, Guo Zhou, Ye Yaping, Guo Fengjing
Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, PR China.
Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, PR China.
J Orthop Translat. 2020 Dec 17;27:33-43. doi: 10.1016/j.jot.2020.09.006. eCollection 2021 Mar.
Osteoarthritis (OA) is a complex process comprised of mechanical load, inflammation, and metabolic factors. It is still unknown that if chondrocytes undergo ferroptosis during OA and if ferroptosis contribute to the progression of OA.
In our study, we use Interleukin-1 Beta (IL-1β) to simulate inflammation and ferric ammonium citrate (FAC) to simulate the iron overload . Also, we used the surgery-induced destabilized medial meniscus (DMM) mouse model to induce OA . We verify ferroptosis by its definition that defined by the Nomenclature Committee on Cell Death with both and model.
We observed that both IL-1β and FAC induced reactive oxygen species (ROS), and lipid ROS accumulation and ferroptosis related protein expression changes in chondrocytes. Ferrostatin-1, a ferroptosis specific inhibitor, attenuated the cytotoxicity, ROS and lipid-ROS accumulation and ferroptosis related protein expression changes induced by IL-1β and FAC and facilitated the activation of Nrf2 antioxidant system. Moreover, erastin, the most classic inducer of ferroptosis, promoted matrix metalloproteinase 13 (MMP13) expression while inhibited type II collagen (collagen II) expression in chondrocytes. At last, we proved that intraarticular injection of ferrostatin-1 rescued the collagen II expression and attenuated the cartilage degradation and OA progression in mice OA model.
In summary, our study firstly proved that chondrocytes underwent ferroptosis under inflammation and iron overload condition. Induction of ferroptosis caused increased MMP13 expression and decreased collagen II expression in chondrocytes. Furthermore, inhibition of ferroptosis, by intraarticular injection of ferrostatin-1, in our case, seems to be a novel and promising option for the prevention of OA.
The translation potential of this article is that we first indicated that chondrocyte ferroptosis contribute to the progression of osteoarthritis which provides a novel strategy in the prevention of OA.
骨关节炎(OA)是一个由机械负荷、炎症和代谢因素组成的复杂过程。目前尚不清楚软骨细胞在OA过程中是否会发生铁死亡,以及铁死亡是否会促进OA的进展。
在我们的研究中,我们使用白细胞介素-1β(IL-1β)模拟炎症,柠檬酸铁铵(FAC)模拟铁过载。此外,我们使用手术诱导的内侧半月板不稳定(DMM)小鼠模型来诱导OA。我们通过细胞死亡命名委员会定义的铁死亡定义,在两种模型中验证铁死亡。
我们观察到IL-1β和FAC均诱导软骨细胞中活性氧(ROS)、脂质ROS积累以及铁死亡相关蛋白表达变化。铁死亡特异性抑制剂Ferrostatin-1减弱了IL-1β和FAC诱导的细胞毒性、ROS和脂质ROS积累以及铁死亡相关蛋白表达变化,并促进了Nrf2抗氧化系统的激活。此外,最经典的铁死亡诱导剂埃拉斯汀促进软骨细胞中基质金属蛋白酶13(MMP13)表达,同时抑制II型胶原蛋白(胶原蛋白II)表达。最后,我们证明关节内注射Ferrostatin-1可挽救小鼠OA模型中胶原蛋白II的表达,并减轻软骨降解和OA进展。
总之,我们的研究首次证明软骨细胞在炎症和铁过载条件下会发生铁死亡。铁死亡的诱导导致软骨细胞中MMP13表达增加和胶原蛋白II表达减少。此外,在我们的研究中,通过关节内注射Ferrostatin-1抑制铁死亡似乎是预防OA的一种新的有前景的选择。
本文的转化潜力在于我们首次表明软骨细胞铁死亡促进骨关节炎的进展,这为预防OA提供了一种新策略。